Back to briefing
Research Switzerland

Melanoma Detection in Switzerland with VECTRA

This research compares 2D and 3D imaging techniques with routine clinical care for early melanoma detection in a prospective, large-scale real‑world dataset collected in Switzerland. The study evaluates the effectiveness of VECTRA imaging technology in improving diagnostic accuracy. Data were gathered from a real-world clinical setting across Switzerland.

Published
28 Oct 2020
2 min read 1 source
Intelligence brief
Switzerland / Research
CH

This research compares 2D and 3D imaging techniques with routine clinical care for early melanoma detection in a prospective, large-scale real‑world dataset collected in Switzerland. The study evaluates the effectiveness of VECTRA imaging technology in improving diagnostic accuracy. Data were gathered from a real-world clinical setting across Switzerland.

Why it matters

It informs the integration of AI‑driven imaging solutions into Swiss dermatological practice, supporting national efforts to enhance early cancer detection.

Primary source record
ClinicalTrials.gov

Original source record. Open the original record to verify the underlying announcement.

Your privacy choices

Allow optional Google Analytics to help us understand how the site is used. Analytics stays off unless you accept. Privacy details